Reducing cardiovascular disease and complications among Hispanic diabetes patients in Arizona is the focus of a new research project for Tomas Nuño, PhD, assistant professor of public health practice and translational research at the UA Mel and Enid Zuckerman College of Public Health – Phoenix and the Department of Emergency Medicine at the UA College of Medicine – TucsonContinue reading
NASA grant will allow the Center for Applied NanoBioscience and Medicine to study the health effects of long space missionsContinue reading
Second study to probe whether an investigational drug can prevent or delay the emergence of symptoms in high-risk older adultsContinue reading
The 2017 AZBio Trailblazer Honorees are: House Speaker JD Mesnard, Senator Nancy Barto, Senator Kimberly Yee, Senator Kate Brophy McGee, Representative Lela Alston, Representative Heather Carter, Representative Regina Cobb, DDS, Representative Randall Friese, MD, and Representative Jay Lawrence.Continue reading
The Arizona Commerce Authority has announced the 25 semifinalists in the Fall 2017 round of the Arizona Innovation Challenge. The semifinalists include: Breezing Co. (Tempe), GT Medical Technologies (Gilbert), Life365 Inc. (Tempe), Merchant’s Garden AgroTech Inc. (Tucson), MicronView LLC (Tucson), NanoPin Technologies Inc. (Phoenix), Resonea (Scottsdale), SkinSafe Inc. (Scottsdale), and VB Cosmetics Inc. (Chandler).Continue reading
Stephen Munk has joined the Biodesign Institute at Arizona State University as deputy director of science and technology. In this role, Munk will focus on the strategic, business and technical operations of Arizona’s single largest bioscience research infrastructure investment.Continue reading
A University of Arizona Cancer Center and College of Agriculture and Life Sciences research team is engaged in a series of studies to investigate how genistein, a component of soy foods, might suppress the development of breast cancer.Continue reading
Tucson, Ariz. – Researchers in the University of Arizona College of Medicine – Tucson have invented a new class of non-opioid compounds to treat pain. Animal testing has shown that the drug candidates are more effective than morphine, non-addictive, and non-toxic at high doses. The UA has licensed the compounds to startup Regulonix. Continue reading
The University of Arizona has licensed a drug that aims to shorten the lives of cancer cells to startup Reglagene. The technology, invented at the UA College of Pharmacy and the UA BIO5 Institute by Laurence Hurley, PhD, and Vijay Gokhale, PhD, has been shown to be effective in shortening the lives of target cells, essentially inducing cancer cells to grow old and die.Continue reading
